Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.